Pall India, Spinchrom Ink Indian Distribution Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Pall today announced an exclusive distribution deal covering India between Pall India and Spinchrom Life Sciences, a division of Spinco Biotech.

Spinchrom, which on focuses on the life sciences and consumables markets, will be the exclusive distributor in India of ForteBio's Blitz system for the label-free analysis of proteins with small sample volumes. ForteBio is a division of Pall Life Sciences and supplies label-free technology for the development of biotherapeutic and pharmaceutical products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.